ArticleBMC cancer2011

Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.

Steffen Wedel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.